---
short_name: C.S. Rhymes
title: C.S. Rhymes - web dev and author
name: C.S. Rhymes
position: Web Designer
description: C.S. Rhymes is a web developer and a part time author, specialising in Laravel, Vue.js and developing Jekyll themes.
image: /img/post4.png
hero_image: /img/post4.png
avatar: /img/avatar.png
website: https://www.csrhymes.com
facebook: https://www.facebook.com/
twitter: https://www.twitter.com/chrisrhymes
github: https://www.github.com/chrisrhymes
gitlab: https://www.gitlab.com
instagram: https://www.instagram.com
linkedin: https://www.linkedin.com/in/chris-rhymes-a6a85971
medium: https://www.medium.com/@chrisrhymes
stack_overflow: https://stackoverflow.com/
---
C.S. Rhymes is a web developer and a part time author, specialising in Laravel, Vue.js and developing Jekyll themes.

This theme was built by C.S. Rhymes as well as the [Bulma Clean Theme](https://www.csrhymes.com/bulma-clean-theme). 

Latest Works

1.Cancer Heterogeneity Analysis and Personalized Therapy Development Using Single-Cell Sequencing
Research Focus: Utilize single-cell RNA sequencing to analyze tumor microenvironment heterogeneity, identify cell populations associated with drug resistance, and develop personalized treatment strategies.

2.Application of Genome Editing in Precision Oncology: CRISPR-Cas9 Targeted Therapy
Research Focus: Explore the use of CRISPR-Cas9 technology to precisely edit the genomes of cancer cells, investigating its potential and challenges in cancer treatment.

3.Development of Precision Diagnostic and Risk Prediction Models for Cardiovascular Diseases Based on Multi-Omics Data
Research Focus: Integrate genomics, transcriptomics, and proteomics data to create multivariable risk prediction models for cardiovascular diseases, optimizing early diagnosis and personalized treatment approaches.

4.The Role of the Microbiome in Immunotherapy and Its Application in Cancer Treatment
Research Focus: Investigate how the gut microbiome influences the efficacy of immune checkpoint inhibitors and explore methods to enhance cancer immunotherapy outcomes by modulating the microbiome.
